Get started
Author

Federica D’Angelo

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial
2017 · Olga Vaccaro, Maria Masulli, et al. · The Lancet Diabetes & Endocrinology · 299
Adverse Drug Events as a Cause of Hospitalization in Older Adults
2012 · Fabio Salvi, Annalisa Marchetti, et al. · Drug Safety · 153
Polyphenol intake and cardiovascular risk factors in a population with type 2 diabetes: The TOSCA.IT study
2016 · Marilena Vitale, Olga Vaccaro, et al. · Clinical Nutrition · 80
PDF
Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes)
2017 · G.P. Fadini, G. Zatti, et al. · Nutrition Metabolism and Cardiovascular Diseases · 30
Artificial intelligence in cardiology: a peek at the future and the role of ChatGPT in cardiology practice
2024 · Cristina Madaudo, Antonio Luca Maria Parlati, et al. · Journal of Cardiovascular Medicine · 28
Comparative Effectiveness of DPP-4 Inhibitors Versus Sulfonylurea for the Treatment of Type 2 Diabetes in Routine Clinical Practice: A Retrospective Multicenter Real-World Study
2018 · Gian Paolo Fadini, Daniele Bottigliengo, et al. · Diabetes Therapy · 19
PDF
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes
2021 · V. Sciannameo, P. Berchialla, et al. · Cardiovascular Diabetology · 9
PDF
Discontinuously supervised aerobic training vs. physical activity promotion in the self-management of type 2 diabetes in older Italian patients: design and methods of the ‘TRIPL-A’ randomized controlled trial
2019 · Francesco Lucertini, Carlo Ferri Marini, et al. · BMC Geriatrics · 9
PDF
Author response for "Enrolment criteria for diabetes cardiovascular outcome trials do not inform on generalizability to clinical practice. The case of GLP‐1 receptor agonists"
2019 · Veronica Sciannameo, Paola Berchialla, et al. · Publons reviews and discussion
Dapagliflozin: innovazione ed efficacia terapeutica. Caso clinico
2016 · Federica D’Angelo · MEDIA - Aggiornamento e formazione in diabetologia e malattie metaboliche
Works count: 12
Citation count: 646
H-index: 9
I10-index: 7
Year
Topic
Type